⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001235445

SCHLACHET DAVID

Reports to the SEC for 3 companies · JERUSALEM, L3

Transactions

7

Companies

3

Filings

6

CIK

0001235445

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-07-01	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Director	AAward	+20K sh	—	—	20,000
2016-07-01	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Director	AAward	+20K sh	—	—	20,000
2015-07-01	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Director	AAward	+20K sh	—	—	20,000
2014-10-08	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director	PPurchase	+32.1K sh	$3.12	+$100K	32,050
2014-07-01	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Director	AAward	+20K sh	—	—	20,000
2014-07-01	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Director	AAward	+20K sh	—	—	20,000
2005-02-16	PHARMOS CORPStock OptionsA Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

6

Accepted (ET)
Jul 54
BIOTIME INC0001209191-17-043813
SEC(opens sec.gov)
Jul 54
BIOTIME INC0001209191-16-131354
SEC(opens sec.gov)
Jul 64
BIOTIME INC0001209191-15-059862
SEC(opens sec.gov)
Oct 104
BIOTIME INC0001209191-14-062970
SEC(opens sec.gov)
Jul 34
BIOTIME INC0001209191-14-046135
SEC(opens sec.gov)
Feb 224
SCHLACHET DAVID0001297596-05-000005
SEC(opens sec.gov)

Companies

3

Address

BECK SCIENCE CENTER 8 HARTOM ST

JERUSALEM, L3, 97775